SPDR S&P Biotech (XBI) 68.47 $XBI
SPDR S&P Biotech ETF Falls 2.15% on Heavy Volume: Watch For Potential Rebound
Comtex SmarTrend(R) - Thu Nov 12, 6:54PM CST
SPDR S&P Biotech ETF (AMEX:XBI) traded in a range yesterday that spanned from a low of $68.15 to a high of $70.00. Yesterday, the shares fell 2.1%, which took the trading range below the 3-day low of $69.65 on volume of 3.3 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
XBI: 68.47 (+0.32)
Buy Amgen's Healthy Dividend, Hold for Its Growth Prescription
at The Street - Tue Nov 10, 6:05AM CST
Amgen's dividend may be just on par with the S&P 500's average, but its forward earnings ratio and price target make it a solid buy-and-hold candidate.
BIIB: 281.04 (-2.49), XBI: 68.47 (+0.32), ALXN: 170.78 (+1.87), AMGN: 158.00 (+3.50)
Top ETF Stories to Watch for in November
Zacks Equity Research - Zacks Investment Research - Wed Nov 04, 11:22AM CST
Inside the top financial stories and their impact on the world of ETFs which could be in watch in November.
BSJG: 26.05 (+0.05), KRE: 44.48 (+0.20), EUSC: 25.40 (+0.02), SBIO: 30.80 (+0.29), CNXT: 43.24 (-1.18), XBI: 68.47 (+0.32), ECNS: 45.39 (+0.39), UUP: 25.94 (+0.04), HEWG: 25.32 (+0.18)
After Yesterday's Rally of 6.56% Shares Could Potentially Pullback
Comtex SmarTrend(R) - Mon Nov 02, 4:15PM CST
SPDR S&P Biotech ETF (AMEX:XBI) traded in a range yesterday that spanned from a low of $66.63 to a high of $71.10. Yesterday, the shares gained 6.6%, which took the trading range above the 3-day high of $70.12 on volume of 4.7 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
XBI: 68.47 (+0.32)
The Top 3 Biotech ETFs on the Market
Brian Feroldi, The Motley Fool - Motley Fool - Sun Nov 01, 3:09PM CST
Photo by Bill Brooks Flickr Creative Commons. Biotech investing is not for the faint of heart . The industry is chock-full of companies that don't even have revenue yet, let alone profits, which can lead to wild price swings. To make matters...
FBT: 110.02 (+2.00), XBI: 68.47 (+0.32), IBB: 328.62 (+3.73)
Look for Shares of SPDR S&P Biotech ETF to Potentially Pullback after Yesterday's 2.19% Rise
Comtex SmarTrend(R) - Tue Oct 27, 4:25PM CDT
SPDR S&P Biotech ETF (AMEX:XBI) traded in a range yesterday that spanned from a low of $65.70 to a high of $67.35. Yesterday, the shares gained 2.2%, which took the trading range above the 3-day high of $67.30 on volume of 4.6 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
XBI: 68.47 (+0.32)
Downtrend Call Working As SPDR S&P Biotech ETF Stock Falls 9.0% (XBI)
Comtex SmarTrend(R) - Thu Oct 22, 9:43AM CDT
SmarTrend identified a Downtrend for SPDR S&P Biotech ETF (AMEX:XBI) on September 25th, 2015 at $69.95. In approximately 4 weeks, SPDR S&P Biotech ETF has returned 9.01% as of today's recent price of $63.65.
XBI: 68.47 (+0.32)
Shareholder Alert: 4 Stocks Ready to Make a Move
ACCESSWIRE - Mon Oct 19, 11:17AM CDT
WINDSOR, ONTARIO / ACCESSWIRE / October 19, 2015 / The Wealthy Biotech Trader (or "WBT"
, an investment newsletter focused on showing everyday investors new opportunities in rapidly growing, little-known, biotech, pharma, medical device and general healthcare stocks making news and subsequent market moves, is alerting traders about several trade ideas within the very healthy medical device sector.
LOXO: 31.51 (+2.67), XBI: 68.47 (+0.32), FORD: 1.41 (+0.01)
Watch for SPDR S&P Biotech ETF to Potentially Rebound After Falling 4.41% Yesterday
Comtex SmarTrend(R) - Tue Oct 13, 4:00PM CDT
SPDR S&P Biotech ETF (AMEX:XBI) traded in a range yesterday that spanned from a low of $61.16 to a high of $65.20. Yesterday, the shares fell 4.4%, which took the trading range below the 3-day low of $61.38 on volume of 5.0 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
XBI: 68.47 (+0.32)
SPDR S&P Biotech ETF Down 7.4% Since SmarTrend Downtrend Call (XBI)
Comtex SmarTrend(R) - Tue Oct 13, 11:54AM CDT
SmarTrend identified a Downtrend for SPDR S&P Biotech ETF (AMEX:XBI) on September 25th, 2015 at $69.95. In approximately 3 weeks, SPDR S&P Biotech ETF has returned 7.38% as of today's recent price of $64.79.
XBI: 68.47 (+0.32)
Zacks Investment Ideas feature highlights: iShares Nasdaq Biotechnology, SPDR S&P Biotech ETF, ProShares Short S&P500, ProShares UltraShort S&P500 and ProShares UltraPro Short S&P500
Zacks Equity Research - Zacks Investment Research - Mon Oct 12, 8:30AM CDT
Zacks Investment Ideas feature highlights: iShares Nasdaq Biotechnology, SPDR S&P Biotech ETF, ProShares Short S&P500, ProShares UltraShort S&P500 and ProShares UltraPro Short S&P500
SPXU: 32.13 (+0.07), SH: 20.93 (+0.01), SDS: 20.07 (+0.02), XBI: 68.47 (+0.32), IBB: 328.62 (+3.73)
Protea: A High Quality Small-Cap to Ride Out Biotech's Drop
ACCESSWIRE - Mon Oct 12, 8:16AM CDT
REDONDO BEACH, CA / ACCESSWIRE / October 12, 2015 / The SPDR S&P Biotech ETF (ARCA: XBI) has fallen more than 20% over the past three months, which significantly outpaced the S&P 500's 4.7% fall over the same timeframe. With the House of Representatives subpoenaing Valeant Pharmaceuticals International Inc. (NYSE: VRX) for documents related to drug price increases, the market is concerned that the federal government may be stepping up its efforts to curb increases in drug prices.
VRX: 70.84 (-2.48), FMI: 16.24 (-0.27), XBI: 68.47 (+0.32), WAT: 131.45 (+0.93), VRX.TO: 94.35 (-3.44)
Juno Therapeutics (JUNO) Stock Could Lead the Way to a Biotech Bounce
at The Street - Fri Oct 09, 10:40AM CDT
We're watching the SPDR S&P Biotech ETF and its components for clues to a rally. Rejected lows in the charts have been encouraging.
XBI: 68.47 (+0.32), JUNO: 52.35 (-1.12)
Charting a Biotech Bounce
at The Street - Fri Oct 09, 10:10AM CDT
We're watching the SPDR S&P Biotech ETF for clues to a rally. Rejected lows in the charts have been encouraging.
XBI: 68.47 (+0.32), JUNO: 52.35 (-1.12)
7 Huge Mistakes Every ETF Investor Needs to Avoid
Eric Dutram - Zacks Investment Research - Fri Oct 09, 9:45AM CDT
These are some of the most common misconceptions about ETF investing, make sure you do not make the same mistakes!
SPY: 205.46 (-0.16), VXX: 20.62 (+0.87), GLD: 102.61 (-1.10), XBI: 68.47 (+0.32), IBB: 328.62 (+3.73), IAU: 10.35 (-0.11)
Correction in Health Care Stocks Remains in Full Force
at The Street - Thu Oct 08, 3:00PM CDT
Have we reached the point where something will be done about it?
CI: 134.00 (+0.51), ANTM: 136.06 (+1.00), HCA: 68.99 (+1.79), XBI: 68.47 (+0.32), UNH: 114.40 (+0.58), IBB: 328.62 (+3.73), XLV: 70.67 (+0.23)
3 Large-Cap Biotech Stocks Whose Valuations Should Make You Skeptical
Sean Williams, The Motley Fool - Motley Fool - Wed Oct 07, 7:03AM CDT
Source: Federal Reserve Bank of New York. With the exception of the last couple of weeks, the biotech sector has been a vast outperformer since the Great Recession. The broad-based S&P 500 has pretty much tripled since hitting its lows in...
BIIB: 281.04 (-2.49), VRTX: 127.61 (+2.33), XBI: 68.47 (+0.32), INCY: 112.52 (+4.46)
SPDR S&P Biotech ETF Rises 4.89% on Heavy Volume: Watch For Potential Pullback
Comtex SmarTrend(R) - Fri Oct 02, 4:07PM CDT
SPDR S&P Biotech ETF (AMEX:XBI) traded in a range yesterday that spanned from a low of $60.45 to a high of $65.75. Yesterday, the shares gained 4.9%, which took the trading range above the 3-day high of $64.56 on volume of 9.1 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
XBI: 68.47 (+0.32)
SPDR S&P Biotech ETF Falls 2.15% on Heavy Volume: Watch For Potential Rebound
Comtex SmarTrend(R) - Thu Nov 12, 6:54PM CST
SPDR S&P Biotech ETF (AMEX:XBI) traded in a range yesterday that spanned from a low of $68.15 to a high of $70.00. Yesterday, the shares fell 2.1%, which took the trading range below the 3-day low of $69.65 on volume of 3.3 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
XBI: 68.47 (+0.32)
Buy Amgen's Healthy Dividend, Hold for Its Growth Prescription
at The Street - Tue Nov 10, 6:05AM CST
Amgen's dividend may be just on par with the S&P 500's average, but its forward earnings ratio and price target make it a solid buy-and-hold candidate.
BIIB: 281.04 (-2.49), XBI: 68.47 (+0.32), ALXN: 170.78 (+1.87), AMGN: 158.00 (+3.50)
Top ETF Stories to Watch for in November
Zacks Equity Research - Zacks Investment Research - Wed Nov 04, 11:22AM CST
Inside the top financial stories and their impact on the world of ETFs which could be in watch in November.
BSJG: 26.05 (+0.05), KRE: 44.48 (+0.20), EUSC: 25.40 (+0.02), SBIO: 30.80 (+0.29), CNXT: 43.24 (-1.18), XBI: 68.47 (+0.32), ECNS: 45.39 (+0.39), UUP: 25.94 (+0.04), HEWG: 25.32 (+0.18)
After Yesterday's Rally of 6.56% Shares Could Potentially Pullback
Comtex SmarTrend(R) - Mon Nov 02, 4:15PM CST
SPDR S&P Biotech ETF (AMEX:XBI) traded in a range yesterday that spanned from a low of $66.63 to a high of $71.10. Yesterday, the shares gained 6.6%, which took the trading range above the 3-day high of $70.12 on volume of 4.7 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
XBI: 68.47 (+0.32)
The Top 3 Biotech ETFs on the Market
Brian Feroldi, The Motley Fool - Motley Fool - Sun Nov 01, 3:09PM CST
Photo by Bill Brooks Flickr Creative Commons. Biotech investing is not for the faint of heart . The industry is chock-full of companies that don't even have revenue yet, let alone profits, which can lead to wild price swings. To make matters...
FBT: 110.02 (+2.00), XBI: 68.47 (+0.32), IBB: 328.62 (+3.73)
Look for Shares of SPDR S&P Biotech ETF to Potentially Pullback after Yesterday's 2.19% Rise
Comtex SmarTrend(R) - Tue Oct 27, 4:25PM CDT
SPDR S&P Biotech ETF (AMEX:XBI) traded in a range yesterday that spanned from a low of $65.70 to a high of $67.35. Yesterday, the shares gained 2.2%, which took the trading range above the 3-day high of $67.30 on volume of 4.6 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
XBI: 68.47 (+0.32)
Downtrend Call Working As SPDR S&P Biotech ETF Stock Falls 9.0% (XBI)
Comtex SmarTrend(R) - Thu Oct 22, 9:43AM CDT
SmarTrend identified a Downtrend for SPDR S&P Biotech ETF (AMEX:XBI) on September 25th, 2015 at $69.95. In approximately 4 weeks, SPDR S&P Biotech ETF has returned 9.01% as of today's recent price of $63.65.
XBI: 68.47 (+0.32)
Shareholder Alert: 4 Stocks Ready to Make a Move
ACCESSWIRE - Mon Oct 19, 11:17AM CDT
WINDSOR, ONTARIO / ACCESSWIRE / October 19, 2015 / The Wealthy Biotech Trader (or "WBT"
, an investment newsletter focused on showing everyday investors new opportunities in rapidly growing, little-known, biotech, pharma, medical device and general healthcare stocks making news and subsequent market moves, is alerting traders about several trade ideas within the very healthy medical device sector. LOXO: 31.51 (+2.67), XBI: 68.47 (+0.32), FORD: 1.41 (+0.01)
Watch for SPDR S&P Biotech ETF to Potentially Rebound After Falling 4.41% Yesterday
Comtex SmarTrend(R) - Tue Oct 13, 4:00PM CDT
SPDR S&P Biotech ETF (AMEX:XBI) traded in a range yesterday that spanned from a low of $61.16 to a high of $65.20. Yesterday, the shares fell 4.4%, which took the trading range below the 3-day low of $61.38 on volume of 5.0 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
XBI: 68.47 (+0.32)
SPDR S&P Biotech ETF Down 7.4% Since SmarTrend Downtrend Call (XBI)
Comtex SmarTrend(R) - Tue Oct 13, 11:54AM CDT
SmarTrend identified a Downtrend for SPDR S&P Biotech ETF (AMEX:XBI) on September 25th, 2015 at $69.95. In approximately 3 weeks, SPDR S&P Biotech ETF has returned 7.38% as of today's recent price of $64.79.
XBI: 68.47 (+0.32)
Zacks Investment Ideas feature highlights: iShares Nasdaq Biotechnology, SPDR S&P Biotech ETF, ProShares Short S&P500, ProShares UltraShort S&P500 and ProShares UltraPro Short S&P500
Zacks Equity Research - Zacks Investment Research - Mon Oct 12, 8:30AM CDT
Zacks Investment Ideas feature highlights: iShares Nasdaq Biotechnology, SPDR S&P Biotech ETF, ProShares Short S&P500, ProShares UltraShort S&P500 and ProShares UltraPro Short S&P500
SPXU: 32.13 (+0.07), SH: 20.93 (+0.01), SDS: 20.07 (+0.02), XBI: 68.47 (+0.32), IBB: 328.62 (+3.73)
Protea: A High Quality Small-Cap to Ride Out Biotech's Drop
ACCESSWIRE - Mon Oct 12, 8:16AM CDT
REDONDO BEACH, CA / ACCESSWIRE / October 12, 2015 / The SPDR S&P Biotech ETF (ARCA: XBI) has fallen more than 20% over the past three months, which significantly outpaced the S&P 500's 4.7% fall over the same timeframe. With the House of Representatives subpoenaing Valeant Pharmaceuticals International Inc. (NYSE: VRX) for documents related to drug price increases, the market is concerned that the federal government may be stepping up its efforts to curb increases in drug prices.
VRX: 70.84 (-2.48), FMI: 16.24 (-0.27), XBI: 68.47 (+0.32), WAT: 131.45 (+0.93), VRX.TO: 94.35 (-3.44)
Juno Therapeutics (JUNO) Stock Could Lead the Way to a Biotech Bounce
at The Street - Fri Oct 09, 10:40AM CDT
We're watching the SPDR S&P Biotech ETF and its components for clues to a rally. Rejected lows in the charts have been encouraging.
XBI: 68.47 (+0.32), JUNO: 52.35 (-1.12)
Charting a Biotech Bounce
at The Street - Fri Oct 09, 10:10AM CDT
We're watching the SPDR S&P Biotech ETF for clues to a rally. Rejected lows in the charts have been encouraging.
XBI: 68.47 (+0.32), JUNO: 52.35 (-1.12)
7 Huge Mistakes Every ETF Investor Needs to Avoid
Eric Dutram - Zacks Investment Research - Fri Oct 09, 9:45AM CDT
These are some of the most common misconceptions about ETF investing, make sure you do not make the same mistakes!
SPY: 205.46 (-0.16), VXX: 20.62 (+0.87), GLD: 102.61 (-1.10), XBI: 68.47 (+0.32), IBB: 328.62 (+3.73), IAU: 10.35 (-0.11)
Correction in Health Care Stocks Remains in Full Force
at The Street - Thu Oct 08, 3:00PM CDT
Have we reached the point where something will be done about it?
CI: 134.00 (+0.51), ANTM: 136.06 (+1.00), HCA: 68.99 (+1.79), XBI: 68.47 (+0.32), UNH: 114.40 (+0.58), IBB: 328.62 (+3.73), XLV: 70.67 (+0.23)
3 Large-Cap Biotech Stocks Whose Valuations Should Make You Skeptical
Sean Williams, The Motley Fool - Motley Fool - Wed Oct 07, 7:03AM CDT
Source: Federal Reserve Bank of New York. With the exception of the last couple of weeks, the biotech sector has been a vast outperformer since the Great Recession. The broad-based S&P 500 has pretty much tripled since hitting its lows in...
BIIB: 281.04 (-2.49), VRTX: 127.61 (+2.33), XBI: 68.47 (+0.32), INCY: 112.52 (+4.46)
SPDR S&P Biotech ETF Rises 4.89% on Heavy Volume: Watch For Potential Pullback
Comtex SmarTrend(R) - Fri Oct 02, 4:07PM CDT
SPDR S&P Biotech ETF (AMEX:XBI) traded in a range yesterday that spanned from a low of $60.45 to a high of $65.75. Yesterday, the shares gained 4.9%, which took the trading range above the 3-day high of $64.56 on volume of 9.1 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
XBI: 68.47 (+0.32)
